JPRN-UMIN000021247已完成未知
Tocilizumab treatment with reducing and stopping methotrexate in patients with rheumatoid arthritis in stable low disease activity-state - Tocilizumab treatment with reducing and stopping methotrexate (T-ReX study)
agoya University Hospital0 个研究点目标入组 53 人开始时间: 2016年7月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 53
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients receiving TCZ and/or MTX for any disease other than RA 2) Patients judged as inadequate at the discretion of physicians
研究者
相似试验
尚未招募
2 期
Tocilizumab for the treatment of retroperitoneal fibrosisretroperitoneal fibrosisACTRN12618000922279Azienda Ospedaliero Universitaria di Parma18
已完成
不适用
T-ReX studyRheumatoid arthritisJPRN-jRCTs041180071Kojima Toshihisa53
进行中（未招募）
2 期
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord TransplantationHematologic MalignancyBone Marrow TransplantNCT04395222Weill Medical College of Cornell University21
已完成
不适用
Tocilizumab treatment of cyclophosphamide-resistant patients with ANCA-associated vasculitisANCA-associated vasculitisJPRN-UMIN000002892Research Committee of multicentre clinical trials for intractable ANCA-associated vasculitis of the Ministry of Health, Labor and Welfare of Japan5
已完成
2 期
Effect of TOCILIZUMAB (ACTEMRA) on treatment of COVID-19COVID-19 disease.COVID-19, virus not identifiedU07.2IRCT20081027001411N4Tehran University of Medical Sciences40